Abstract Treatment of Helicobacter pylori infection is important for the management of
gastrointestinal disorders such as peptic ulcer and gastric cancer. Due to the increase in the …

Helicobacter pylori (H. pylori) is considered an etiologic factor for the development of peptic
ulcer disease, gastric adenocarcinoma, and MALT lymphoma. Therapeutic schemes to …

After the discovery of Helicobacter pylori (H. pylori), and the evidence of its relationship with
gastric diseases, antibiotic-based therapies were developed, which efficacy was however …

Helicobacter pylori is a common human pathogen infecting about 30% of children and 60%
of adults worldwide and is responsible for diseases such as gastritis, peptic ulcer and gastric …

Infection with the Gram-negative pathogen Helicobacter pylori (H. pylori) has been
associated with gastro-duodenal disease and the importance of H. pylori eradication is …

The prevalence of Helicobacter pylori infection remains significant worldwide and it depends
on many factors: gender, age, socio-economic status, geographic area, diet, and lifestyle. All …

Helicobacter pylori (H. pylori) is a Gram-negative anaerobic bacterium that colonizes the
human stomach and is the leading cause of gastric diseases such as chronic gastritis and …

Helicobacter pylori, a member of Epsilonproteobacteria, is a Gram-negative microaerophilic
bacterium that colonizes gastric mucosa of about 50% of the human population. Although …

Background The treatment for the eradication of Helicobacter pylori (H. pylori) is complex;
full effectiveness is rarely achieved and it has many adverse effects. In developing countries …

Helicobacter pylori is a highly prevalent human pathogen responsible for chronic
inflammation of the gastric tissues, gastroduodenal ulcers, and cancer. The treatment …